Who is sponsoring NCT03626883?

NCT03626883 is sponsored by Rafał Kamiński.

What drugs are being tested in NCT03626883?

Interventions in NCT03626883: single-bundle, single-hamstring ACL reconstruction, single-bundle, double-hamstring ACL reconstruction.

What condition does NCT03626883 study?

NCT03626883 studies Anterior Cruciate Ligament Injury.

Is NCT03626883 still recruiting?

NCT03626883 is currently status unknown. Last updated 21 February 2022.

Last reviewed 2022-02-21 · How we verify

NCT03626883: 1vs2ham

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single Versus Double Hamstring Harvest for Anterior Cruciate Ligament Reconstruction

Status unknown NA Last updated 21 February 2022

What this trial tests

NA trial testing single-bundle, single-hamstring ACL reconstruction in Anterior Cruciate Ligament Injury in 120 participants. Status unknown.

Timeline

1 December 2015

Primary endpoint
30 January 2020

30 July 2022

Quick facts

Lead sponsor	Rafał Kamiński
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	120
Start date	1 December 2015
Primary completion	30 January 2020
Estimated completion	30 July 2022
Sites	1 location across Poland

Drugs / interventions tested

single-bundle, single-hamstring ACL reconstruction
single-bundle, double-hamstring ACL reconstruction

Conditions studied

Anterior Cruciate Ligament Injury — all drugs for Anterior Cruciate Ligament Injury →

Sponsor

Rafał Kamiński

Who can join

Adults 18 to 45, any sex, with Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to examine the influence of number of the harvested hamstring tendons on subjective and objective outcomes of primary anterior cruciate ligament reconstruction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Anterior Cruciate Ligament Reconstruction Using a 4-Strand Semitendinosus Tendon Graft or a Doubled Semitendinosus and Gracilis Tendon Graft: A 4.5-Year Prospective, Randomized, Double-Blind, Parallel-Group Study.
Kuliński K, Waśko MK, Tramś E, Malesa K, et al · · 2023 · cited 11× · PMID 36856280 · DOI 10.1177/03635465221149738

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Injury

Currently open trials in the same condition.

NCT06357091 — ACL Reconstruction With Shark Screw® or Biocomposite-interference Screws · NA · recruiting
NCT05527171 — Virtual Reality Mindfulness Meditation After ACL Reconstruction · NA · recruiting
NCT03935750 — STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon · NA · active not recruiting
NCT03348995 — The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03626883 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rafał Kamiński
Last refreshed: 21 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03626883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing